
Hello
This week’s Eblast features the following items:
-
-
Top News:
* Boceprevir receives expedited review status from the FDA and the EMA
* Pharmasset Reports Positive Results from its HCV Clinical Programs
-
-
Sincerely,
Alan
Alan Franciscus
Executive Director, Hepatitis C Support Project
Editor-in-Chief, HCV Advocate www.hcvadvocate.org
Editor-in-Chief, HBV Advocate www.hbvadvocate.org
.
**Questions and Comments: Questions and/or comments can be directed to alanfranciscus@hcvadvocate.org
**To receive the eblast in your email inbox simply send an e-mail to: listserv@list.hcvadvocate.org with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case.
.
|